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ABStrACt
A histopathological analysis of 13 apocrine gland tumors and 22 sebaceous gland tumors in dogs was performed, 
which were submitted to the Department of Veterinary Pathology from 1 January 2010 to 31 December 2012. An 
association between the immunohistochemical expression of E-cadherin and Ki-67, the type, and the biological 
behavior of the tumors was investigated. The mean age of dogs with apocrine gland tumors was 10.15 years, and 
10.91 years for sebaceous gland tumors. According to the histopathological analysis, 53.8% carcinomas and 46.2% 
adenomas of the apocrine glands were found. In the sebaceous gland tumors, epitheliomas were dominant (50.0%), 
followed by adenomas (36.4%) and carcinomas (13.6%). Survival time in dogs with sebaceous gland tumors was 
shortest in patients with diagnosed epitheliomas, intermediate in adenomas, and longest in carcinomas. The incidence 
of metastases was low in the groups with sebaceous adenomas and epitheliomas, and recurrence was most common 
in carcinomas. The average survival time was about the same for apocrine gland adenomas and carcinomas, with 
a higher incidence of metastases and recurrence for carcinomas. Immunohistochemical analysis of E-cadherin and 
Ki-67 expression confirmed the efficiency of this method for the accurate histological classification of apocrine and 
especially sebaceous gland tumors. The analyzes performed showed that the location and intensity of E-cadherin 
expression can be helpful in predicting the biological behavior of sebaceous gland tumors. In contrast to sebaceous 
gland tumors, the analysis of apocrine gland tumors showed that there was no correlation between E-cadherin 
expression and the biological behavior of apocrine gland tumors.
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skin tumors (SIMKO et al., 2003; GROSS et al., 
2005; HARGIS and GINN, 2008). On the basis of 
histological classification and biological behavior, 
these tumors are classified as benign adenomas 
(AGA) and malignant apocrine gland carcinomas 
(AGC). In the group of sebaceous gland neoplasms, 
Introduction
Skin tumors are the most common neoplasia 
in dogs and one of the most frequent causes 
of death (DOBSON et al., 2002; ŠOŠTARIĆ-
ZUCKERMANN et al., 2013; GRÜNTZIG et al., 
2015). Sebaceous gland tumors account for 6-7% 
and apocrine gland tumors for 3.4-5.1% of all canine 
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(WIJNHOVEN et al., 2000; POLTON et al., 2007; 
RESTUCCI et al., 2009; SHAMIR and EWALD, 
2015; KARABOLOVSKI et al., 2015). 
The aim of this study was to test the existence 
of a correlation between the immunohistochemical 
expression of E-cadherin and Ki-67 with the 
histopathological type of tumors, and the biological 
behavior of tumors, primarily to investigate the 
correlation with survival time, tumor recurrence 
rate and metastasis rate. This type of analysis has 
not yet been performed for E-cadherin expression 
in sebaceous and apocrine gland tumors in dogs. 
According to the results of several studies on 
tumors in humans and dogs (WIJNHOVEN et 
al., 2000; POLTON et al., 2007; RESTUCCI 
et al., 2009; KARABOLOVSKI et al., 2015; 
SABATTINI et al, 2015; BHARDWAJ et al., 
2019), the hypothesis of this research was that in 
more malignant apocrine and sebaceous gland 
tumors the expression of E-cadherin is weaker and 
changed from membranous to cytoplasmic and, in 
contrast, Ki-67 expression is higher in malignant 
versus benign tumor types.
Materials and methods
Histopathological analysis. The study was 
performed on samples of canine apocrine 
and sebaceous gland tumors presented for 
histopathological analysis at the Department of 
Veterinary Pathology of the Faculty of Veterinary 
Medicine of the University of Zagreb, collected in 
the period from January 1, 2010 to December 31, 
2012. The samples were from animals that were 
surgically treated at the Clinics of the Faculty 
of Veterinary Medicine, Zagreb, and in private 
practices throughout Croatia. The samples were 
fixed in 10% neutral buffered formalin and then 
embedded in paraffin wax, and 5 μm sections were 
stained with hematoxylin and eosin (H&E) for 
routine histopathological examination. The H&E 
stained sections of the tissues were classified by 
two experienced pathologists, according to the 
diagnostic criteria proposed by the World Health 
Organization (WHO) (GOLDSCHMIDT et al., 
1998).
Immunohistochemistry. Immunohistochemical 
analysis was performed on 5 μm sections of 
besides adenoma (SGA) and the carcinomas (SGC), 
there is a third type of semimalignant neoplasias 
called epitheliomas (SGE) (GOLDSCHMIDT et 
al., 1998; GOLDSCHMIDT and HENDRICK, 
2002; GROSS et al., 2005; HARGIS and GINN, 
2008).
Although histopathological analysis is the most 
important and accurate method for cancer diagnosis, 
identification of tumor type and estimation of 
biological behavior and prognosis, there are 
sometimes difficulties with histopathological 
analysis (MORRISS and DOBSON, 2001; 
SABATTINI et al., 2015). The determination of 
biological behavior can be particularly difficult 
in the case of well-differentiated carcinomas 
and tumor types that, apart from the malignant 
and benign types, have semi-malignant variants, 
such as the cases with sebaceous gland tumors 
(GOLDSCHMIDT and HENDRICK, 2002; 
GROSS et al., 2005). There is a need for additional 
diagnostic methods to determine the tumor types 
and to estimate the biological behavior. 
Immunohistochemical studies of canine 
apocrine gland and sebaceous gland tumors 
show the expression of cytokeratin markers, 
which are important for the determination of 
poorly differentiated tumor types. It may also 
serve a prognostic purpose, e.g. the expression of 
proliferation markers, such as Ki-67 (GUDAN 
KURILJ et al., 2011; SABATTINI et al., 2015).
There are some data in the recent literature 
that show that immunohistochemical analysis of 
E-cadherin expression may be helpful in diagnosing 
and estimating the biological behavior of some 
human and animal tumors (WIJNHOVEN et al., 
2000; POLTON et al., 2007; RESTUCCI et al., 
2009; HAN et al., 2013; SHAMIR and EWALD, 
2015; KARABOLOVSKI et al., 2015)). E-cadherin 
is a transmembrane protein involved in the adhesion 
of epithelial cells and extracellular matrix. The 
reduced or abnormal expression of E-cadherin 
(cytoplasmic, nonmembranous) leads to the weak 
interconnection of tumor cells, and facilitates the 
infiltration of tumor cells into the surrounding 
tissue. It is consequently associated with a higher 
malignancy grade and the shorter survival time of 
human and canine patients with different tumors 
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paraffin-embedded tissue samples. The sections 
were dewaxed in xylene, and rehydrated by a series 
of graded alcohol solutions. Antigen retrieval was 
performed by microwave treatment with citrate 
buffer pH 6 (Dako REALTM Target Retrieval 
Solution, code S2031) for 20 minutes. Endogenous 
peroxidase activity was blocked by incubating 
the slides for 5 minutes at room temperature in 
Dako REAL TM-Peroxidase Blocking Solution 
(DakoCytomation, code S2023). The sections were 
incubated with primary antibodies for 30 minutes, 
with the monoclonal mouse anti-E-cadherin 
antibody (E-cadherin, clone NCH-38, code M3612, 
DAKO) diluted 1:50 and the mouse anti-Ki-67 
monoclonal antibody (Ki-67, clone MIB -1, code 
M7240, DAKO) diluted 1:100. This was followed 
by incubation of 30 min with a ready-to-use 
secondary antibody (Dako REALTM En VisionTM/
HRP, Rabbit/Mouse), and with the substrate Dako 
REAL TM Diaminobenzidine + Chromogen for 
another 10 min. Between each step, rinsing was 
performed with DakoCytomation Wash Buffer. 
The sections were counterstained with hematoxylin 
and mounted. Sections from the normal canine 
circumanal gland were used as the positive control 
for E-cadherin, and the substitution of the primary 
antibody by citrate buffered saline solution was 
used as the negative control.
The evaluation of the immunohistochemical 
reaction of E-cadherin was performed semi-
quantitatively for each tumor. The percentage of 
positive staining, intensity and cellular localization 
of the reaction were evaluated. The percentage of 
tumor cells with positive staining was estimated 
as a positivity score, and graded from 1 to 3. One 
point corresponded to less than 25% staining, 2 
points 25-75%, and 3 points indicated that more 
than 75% of the tumor cells showed positive 
staining. The staining intensity was evaluated as 
0 = negative, 1 = moderate staining, 2 = strong 
staining. The localization was classified as follows: 
-1 = cytoplasmic and 1 = membranous. On the basis 
of the total quantification for each tumor, all values 
were added together to obtain the total score (SUM) 
of the immunohistochemical reaction (RESTUCCI 
et al., 2009; ŠOŠTARIĆ-ZUCKERMANN et 
al., 2016). The Ki-67 reaction was evaluated by 
determining the proliferation index, expressed as a 
percentage of Ki-67-positive cells. This was done 
by counting 1000 cells in 10 high power fields 
(400x), and determining the percentage of Ki-67 
positive cells.
Analysis of the biological behavior of the 
tumors. In order to analyze the biological behavior 
of the tumors, information was collected by 
telephone interviews with the dogs’ veterinarians 
and/or owners, including survival time after tumor 
removal, the occurrence of metastases and the 
recurrence of the tumor at the site of removal. The 
survival time was rated as survival grades: 1: for 
animals that survived up to 12 months after tumor 
removal, 2: 12-24 months, 3: 24-36 months, and 
4: for animals that survived more than 36 months 
after tumor removal. The occurrence of metastases 
was rated 1, the absence of metastases 0. Tumor 
recurrence at the site of removal was rated with 1 
and the non-recurrence 0.
Statistical analysis. The data collected in 
the survey were statistically analyzed using the 
computer program STATISTICA (Data Analysis 
Software System), StatSoft, Inc. (2011), version 10 
www.statsoft.com. The differences between tumor 
type and the results of immunohistochemical and 
biological behavioral analysis were tested using 
the Pearson Hi-square Test. Statistical hypotheses 
were tested at the significance level of P = 0.05, 
i.e. the difference between samples was considered 
significant if P<0.05. 
Results
Sebaceous gland tumors
The samples of seabaceous gland tumors were 
obtained from 22 dogs with a mean age of 10.91 
years (range: 6 to 16 years). The tumors were 
diagnosed in 54.5% (n = 12) males and 45.5% (n 
= 10) females. The most frequently affected breeds 
were mixed breeds (31.8%; n = 7), Golden Retriever 
(27.3%; n = 6) and English Cocker Spaniel (13.6%; 
n = 3); other breeds were represented with a single 
case.
Histopathological analysis. Histopathological 
analysis revealed 11 (50.0%) SBU, 8 (36.4%) SGA 
and 3 (13.6%) SGC.
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Immunohistochemistry. The results of E-cadherin 
and Ki-67 expression in sebaceous gland tumors 
are presented in Table 1.
Fig. 1. SGA, dog, diffuse, strong expression of 
E-cadherin, IHC, E-cadherin, ×200
Sebaceous gland adenoma. The expression of 
E-cadherin was cytoplasmic in 62.5% of SGAs, in 
12.5% membranous and in 25.5% cytoplasmatic 
and membranous. The mean value of cytoplasmic 
expression was -0.86 (SD = 0.35), and that of 
membranous expression 0.38 (SD = 0.52). In 
62.5% of SGAs, E-cadherin was expressed in more 
than 75% of cells (Fig. 1), in 25.5% of adenomas 
E-cadherin was expressed in 25-75% of cells, and 
in 12.5% of SGAs E-cadherin was expressed in less 
than 25% of cells. The mean value of the positivity 
score was 2.5 (SD = 0.76). The expression intensity 
was evaluated as grade 2 in 50% of the SGAs and 
as 1 in 50.0%. The mean value of the expression 
intensity was 1.5 (SD = 0.53).
Fig. 2. SGE, dog, low expression of E-cadherin 
predominantly in differentiated cells, IHC, E-cadherin, ×200
Fig. 3. SGC, low E-cadherin expression; dog, IHC, 
E-cadherin, ×100
The mean value of Ki-67 proliferation index in 
SGAs was 16.67% (SD = 11.11) (Fig. 4a).
Sebaceous gland epithelioma. The expression of 
E-cadherin (Fig. 2) was cytoplasmic in 90.9% of 
SGEs and cytoplasmic and membranous in 9.1%. 
The mean value of the cytoplasmic expression was 
-1 (SD = 0), that of the membranous expression 0.9 
(SD = 0.3). In 45.5% of epitheliomas, E-cadherin 
was expressed in less than 25% of cells, also in 
45.5% of the SGEs it was expressed in 25-75% of 
cells, in 9.1% of SGEs it was expressed in more 
than 75% of cells. In 54.5% of the SGEs E-cadherin 
was expressed in all tumor cells, and in 45.5% of the 
tumors it was expressed only in well-differentiated 
cells (Fig. 5). The mean value of the positivity score 
was 1.66 (SD = 0.67). The expression intensity was 
evaluated as grade 2 in 72.7% of the SGEs and as 
grade 1 in 27.3%. The mean value of the expression 
intensity was 1.33 (SD = 0.58).
In the SGEs, the mean value of the Ki-67 
proliferation index was 18.6% (SD = 7.77) (Fig. 
4b).
Sebaceous gland carcinoma. The expression of 
E-cadherin was cytoplasmic and membranous in 
66.7% of the SGCs and cytoplasmic in 33.3%. The 
mean value of the cytoplasmic expression was -1 
(SD = 0), that of the membranous expression 0.67 
(SD = 0.58). In 66.7% of the SGCs, E-cadherin was 
expressed in less than 25% of cells (Fig. 3), and in 
33.3% of the SGCs it was expressed in more than 
75% of cells. 
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Fig. 4. Sebaceous gland tumors, dogs; a) SGA low Ki-67 expression, b) SGE moderate Ki-67 expression, c) SGC 
high Ki-67 expression; IHC, Ki-67,×400. 
Fig. 5. Mean values and standard deviations of the sum 
of the quantified results for all evaluated parameters for 
E-cadherin and Ki-67 proliferation index of SGA, SGE 
and SGC. 
Fig. 6. The relationship of post-excision survival 
time, expressed as survival grades (1-4) and type of 
sebaceous gland tumor.
In 66.7% of the SGCs, E-cadherin was expressed 
in all tumor cells, and in 33.3% of the tumors it was 
expressed only in well-differentiated cells. The 
mean value of the positivity score was 1.66 (SD = 
1.15). The expression intensity was evaluated as 
grade 2 in 66.7% of the SGCs and as grade 1 in 
33.3%. The mean value of the expression intensity 
was 1.33 (SD = 0.58).
The mean value of the Ki-67 expression 
represented as a proliferation index was 28.5% for 
SGCs (SD = 18.62) (Fig. 4c). 
The results of the E-cadherin and Ki-67 analysis 
for sebaceous gland tumors are shown in Fig. 5 as 
the sum of all quantified results of the evaluated 
parameters for E-cadherin and Ki-67. 
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Analysis of the biological behavior of the tumors. 
The average survival rate of the dogs after surgical 
excisional removal of the tumor was evaluated as 
follows: SGAs - grade 3.00 (SD = 0.71); SGEs - 
grade 2.78 (SD = 1.093), and SGCs - grade 3.50 (SD 
= 0.71). The postoperative survival time of dogs 
with excised sebaceous gland tumors, expressed as 
survival grades (1-4), is shown in Fig. 6.
Fig. 7. AGA, dog, expression of E-cadherin in approx. 
75% of tumor cells, IHC, E-cadherin, ×400
The results of the analysis of the metastatic 
prevalence of sebaceous gland tumors show that 
the average percentage of metastatic prevalence of 
tumors histologically diagnosed as SGA was 16.7% 
(SD = 0.41), for SGE 22.2% (SD = 0.44) and SGC 
0.00% (SD = 0). The average percentage of SGA 
and SGE recurrence was 33.3% (SD = 0.52) and for 
SGC 100% (SD = 0).
Statistical analysis. The performed statistical 
analysis (Chi-square test) showed statistically 
significant differences (P = 0.04035) between 
different tumor types according to their E-cadherin 
expression. The analysis showed statistically 
significant differences between survival times 
depending on the intensity of E-cadherin expression 
(P = 0.041017) and also depending on the 
cytoplasmic distribution of E-cadherin expression 
(P = 0.046662). The results of the statistical analysis 
showed no statistically significant differences 
between different tumor types when correlated with 
the results of Ki-67 expression and the results of the 
biological behavioural analysis.
Apocrine gland tumors
In the three-year period analyzed, 13 samples of 
apocrine gland tumors were found. The mean age 
of the dogs was 10.15 years (range: 1 to 16 years). 
The tumors were diagnosed in 46.1% (n = 6) males, 
38.5% (n = 5) females, and in 15.4% (n = 2) the 
sex was unknown. The most frequently affected 
breeds were mixed breeds (38.5%; n = 5), Golden 
Retrievers (23.1%; n = 3) and German Boxers 
(15.4%; n = 2). Other breeds were represented with 
single cases.
Histopathological analysis. Histopathological 
analysis revealed 6 (46.2%) AGA, and 7 (53.8%) 
AGCs. 
Immunohistochemistry. The results of E-cadherin 
and Ki-67 expression in apocrine gland tumors are 
presented in Table 2. 
Apocrine gland adenoma. The expression of 
E-cadherin was cytoplasmic in 100% of AGAs (Fig. 
7), with a mean value of cytoplasmic expression 1 
(SD = 0) and membranous expression 0 (SD = 0). In 
50.0% of AGAs, E-cadherin was expressed in 25-
75% of the cells (Fig. 11), in 33.3% of the adenomas 
E-cadherin was expressed in more than 75% of the 
cells, and in 16.7% of the AGAs E-cadherin was 
expressed in less than 25% of the cells. The mean 
value of the positivity score was 2.17 (SD = 0.75). 
The expression intensity was evaluated as grade 2 
in 66.7% of the AGAs and as grade 1 in 33.3%. The 
mean value of the expression intensity was 1.67 
(SD = 0.52).
The mean value of the Ki-67 expression was 
7.8% at AGA (SD = 6.02).
Apocrine gland carcinoma. The expression 
of E-cadherin was cytoplasmic in 57.1% of the 
AGCs, cytoplasmic and membranous in 28.6% 
and membranous in 14.3%. The mean value of 
cytoplasmic expression was -0.86 (SD = 0.38), and 
that of membranous expression 0.43 (SD = 0.53). In 
57.1% of AGCs, E-cadherin was expressed in 25-
75% of cells, in 28.6% of tumors in less than 25% of 
cells and in 14.3% of samples in more than 75% of 
cells (Fig. 8). The mean value of the positivity score 
was 1.86 (SD = 0.60). The expression intensity was 
evaluated as grade 1 in 57.1% of the AGCs and 
grade 2 in 42.9%. The mean value of the expression 
intensity was 1.43 (SD = 0.53). 
M. Hohšteter et al.: Expression of E-cadherin and Ki-67 in canine apocrine and sebaceous gland tumors




































































































































































































































































































































































































































M. Hohšteter et al.: Expression of E-cadherin and Ki-67 in canine apocrine and sebaceous gland tumors
Vet. arhiv 91 (1), 51-63, 2021 59
The mean value of Ki-67 expression was 24.1% 
in AGC (SD = 12.92).
Fig. 8. AGC, dog, expression of E-cadherin in more 
than 75% of tumor cells, IHC, E-cadherin, ×200
Fig. 9. Apocrine gland tumors, dogs; a) AGA low Ki-67 
expression, b) AGC high Ki-67 expression; IHC, Ki-67, 
×400.
The results of the E-cadherin and Ki-67 analysis 
for apocrine gland tumors are shown in Fig.10, as 
the sum of all the quantified results of the evaluated 
parameters for E-cadherin and Ki-67.
Analysis of biological behavior of tumors. The 
average survival grade of the dogs after surgical 
removal of the tumor was rated for AGAs with a 
grade of 2.4 (SD = 1.41) and for the AGCs with 
2.33 (SD = 1.37). The postoperative survival time 
of dogs with apocrine gland tumors, expressed as 
survival grades (1-4), is shown in Fig. 11.
 
Fig. 10. Mean values and standard deviations of the sum 
of the quantified results for all evaluated parameters for 
E-Cadherin and Ki-67 proliferation index from AGAs 
and AGCs.
Fig. 11. The relaationship of post-excisional survival 
time, expressed as survival degrees (1-4) and type of 
apocrine gland tumor.
The results of the analysis show that no 
metastases were present in dogs with tumors 
histologically diagnosed as AGAs, and the 
prevalence of metastases was 16.7% in AGCs (SD 
= 0.41). The average percentage of AGA recurrence 
rate was 20.0% (SD = 0.52) and 66.7% (SD = 0.52) 
for AGC.
Statistical analysis. The results of statistical 
analysis (Chi-square test) showed no statistically 
significant differences between different tumor 
types when correlated with the results of E-cadherin 
and Ki-67 expression, and the results of biological 
behavioural analysis.
M. Hohšteter et al.: Expression of E-cadherin and Ki-67 in canine apocrine and sebaceous gland tumors
Vet. arhiv 91 (1), 51-63, 202160
discussion
Sebaceous gland tumors. The results of the 
age and sex analysis of dogs with sebaceous gland 
tumors are consistent with other studies that show 
that these tumors occur most frequently in older dogs 
and that there is no gender-specific predisposition 
(GROSS et al., 2005). The high prevalence of 
sebaceous gland tumors in English Cocker Spaniels 
is also consistent with literature data (GROSS et 
al., 2005). Furthermore, the histological results 
with SGEs as the most common and SGCs as a 
rare tumor types are similar to previous findings 
(GOLDSCHMIDT i HENDRICK, 2002; GROSS 
et al., 2005).
The immunohistochemical analysis showed 
that E-cadherin is expressed least frequently in 
the cytoplasm of SGAs, most frequently in the 
cytoplasm of SGEs and with medium frequency in 
SGCs, when comparing these tumor types. These 
results are analogous to E-cadherin expression of 
mammary gland tumors in dogs and some human 
tumors with membranous expression in benign 
tumors and cytoplasmic expression in more 
malignant tumor types (WIJNHOVEN et al., 2000; 
POLTON et al., 2007; RESTUCCI et al., 2009; 
KARABOLOVSKI et al., 2015; SHAMIR and 
EWALD, 2015). The positivity score of E-cadherin 
expression shows that in histologically benign 
tumor types (SGA) there were more frequent cases 
with the highest number of positive tumor cells. 
The more malignant tumor types (SGE and SGC) 
express E-cadherin in a smaller percentage. The 
expression intensity of E-cadherin was highest for 
SGE and SGC, and lower for SGA. Nevertheless, 
the number of positive cells was higher in benign 
tumors, and in malignant tumors, E-cadherin was 
predominantly expressed in differentiated cells, 
which are only malignantly transformed to a lesser 
extent. The mean values of the sum of the quantified 
results for all evaluated parameters show that the 
highest value occurred in SGAs after SGEs, and the 
lowest in SGCs. 
On the basis of all the estimated immuno-
histochemical results it is obvious that the 
E-cadherin expression is weaker in semimalignant 
and malignant tumor types (SGEs and SGCs), and in 
these tumor types the expression is predominantly 
localized in the cytoplasm, in contrast to benign 
SGAs. Our results suggest that there is a correlation 
between immunohistochemical expression of 
E-cadherin and the histopatological type of 
sebaceous gland tumor, which is consistent with 
the results of studies on other tumor types in 
animals and humans (WIJNHOVEN et al., 2000; 
POLTON et al., 2007; RESTUCCI et al., 2009; 
KARABOLOVSKI et al., 2015; SHAMIR and 
EWALD, 2015). The results of our Ki-67 analysis 
show that semimalignant and malignant tumor types 
have a higher Ki-67 proliferation index, which is 
consistent with the literature data (SABATTINI et 
al., 2015).
The results of the analysis of biological 
behavior show that sebaceous gland tumors that 
are histopathologically assessed as malignant have 
a worse prognosis, with more frequent metastasis 
formation and a higher recurrence rate, which is in 
agreement with the literature data (GOLDSCHMIDT 
and HENDRICK, 2002; GROSS et al., 2005). The 
results on survival time are surprising, as survival 
time was longest in SGCs, but this may be a mere 
consequence of the very low case numbers within 
this tumor type (n = 3).
The determination of metastasis in a case of 
diagnosed SGA, which are tumor types that do 
not metastasize, indicates that there are difficulties 
in the histological differentiation of tumor types. 
There are also possibilities for the classification 
of semimalignant and malignant tumor types 
(e.g. SGEs and well differentiated SGCs) into the 
group of benign tumors, if the differentiation is 
based on histological analysis only. These results 
also indicate the need for additional methods to 
differentiate these tumors.
The results of the statistical analysis, which 
show statistically significant differences (P = 
0.04035) between the values of the results of 
E-cadherin expression in different histological 
types of sebaceous gland tumors, prove our 
hypothesis that immunohistochemical analysis can 
be useful as an additional method to determine the 
type of tumor. These results are compatible with 
the results of Karabolovski et al (2015) on canine 
mammary gland tumors. At the same time, the 
statistical analysis shows statistically significant 
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differences (P = 0.041017) between survival time 
and expression intensity, and statistically significant 
differences (P = 0.046662) between survival time 
and the localization of E-cadherin expression. These 
results suggest opportunities for the application of 
this immunohistochemical assay as a method to 
predict survival time in dogs with sebaceous gland 
adenoma, similar to research on canine apocrine 
anal sac carcinoma (POLTON et al., 2007).
Apocrine gland tumors. The analysis of the age 
and sex analysis of dogs with apocrine gland tumors 
is in agreement with the study by GOLDSCHIMDT 
and HENDRICK (2002), and shows that there is no 
gender-specific predisposition and that these tumors 
occur most frequently in old animals (average age 
10.15 years). In our study, apocrine gland tumors 
occurred most frequently in Golden Retrievers and 
German Boxers. 
The results of our histological analysis show 
that the incidence of AGAs and AGCs is consistent 
with the results of other recent studies (SIMKO et 
al., 2003; GROSS et al., 2005).
Immunohistochemical analyzes showed that 
E-cadherin was cytoplasmically expressed in all 
AGAs, whereas the expression was diversely 
localized in AGCs. There were no differences in 
immunohistochemical positivity score between 
different tumor types. The expression intensity of 
E-cadherin was higher in AGAs and the carcinomas 
expressed E-cadherin to a lesser extent. The mean 
values of the sum of the quantified results for all 
evaluated parameters show that the values for 
AGAs are approximately the same as for AGCs. 
These results of the E-cadherin expression analysis 
are analogous to the results of some studies in 
dogs and human tumors, suggesting that highly 
malignant cells express E-cadherin less than benign 
cells (WIJNHOVEN et al., 2000; POLTON et al., 
2007; RESTUCCI et al., 2009; KARABOLOVSKI 
et al., 2015; SHAMIR and EWALD, 2015). 
The results for other investigated parameters 
of immunohistochemical analysis are not 
compatible with human and animal tumor studies 
(WIJNHOVEN et al., 2000; POLTON et al., 2007; 
RESTUCCI et al., 2009; KARABOLOVSKI et al., 
2015; SHAMIR and EWALD, 2015). The reasons 
for this may be a consequence of the small number 
of tumors analyzed, and the fact that the malignancy 
of the tumor depends on other factors that differ 
from the strength of the tumor cell intertwining 
(CULLEN et al., 2002). The results of the Ki-67 
analysis are consistent with SABATTINI et al. 
(2015) and suggest that malignant apocrine gland 
tumors have a higher Ki-67 proliferation index.
The results of the biological behavioral analysis 
show that there are no significant differences in the 
survival time of dogs with AGAs and AGCs. This 
is an interesting result for tumor survival time for 
apocirne gland tumors, as we could not find data 
for this tumor parameter in the recent literature. 
The results showing more frequent recurrence 
and metastasis formation are consistent with other 
studies conducted for these tumors (SIMKO et al., 
2003; GROSS et al., 2005). 
The statistical analysis showed no statistically 
significant differences between different apocrine 
gland tumor types for the parameters studied, and a 
possible explanation for this may be associated with 
the relatively small number of tumors analyzed, and 
this with the possible errors in obtaining information 
from the owners through a telephone survey are the 
weakest points of this study.
Summarising all the results discussed, 
we conclude that analysis of E-cadherin 
expression may be useful to determine the exact 
histopathological type of apocrine gland tumors 
and especially sebaceous gland tumors in dogs, 
which can be further supported by Ki-67 analysis. 
Although immunohistochemical analysis showed 
no association between E-cadherin and Ki-67 
expression and biological behaviour and prognosis 
in apocrine gland tumors, the study performed 
shows an association between the intensity and 
localization of E-cadherin expression and the 
biological behaviour of sebaceous gland tumors, 
which may be useful for prognostic assessment in 
animals with these tumors.
In order to determine more precisely the 
parameters for estimating the expression of 
E-cadherin and Ki-67 and the relationship to the 
biological behavior of apocrine gland tumors and 
sebaceous gland tumors, studies on the larger 
number of these tumors are necessary.
M. Hohšteter et al.: Expression of E-cadherin and Ki-67 in canine apocrine and sebaceous gland tumors
Vet. arhiv 91 (1), 51-63, 202162
Acknowledgements
This work was partially supported by FP7-ERA Chairs-Pilot 
Call-2013, VetMedZg.
References 
BHARDWAJ, M., S. SEN, K. CHOSDOL, S. BAKHSHI, N. 
PUSHKER, A. SHARMA, S. KASHYAP, M.S. BAJAJ, 
V.K. SINGH (2019): Vimentin overexpression as a novel 
poor prognostic biomarker in eyelid sebaceous gland 
carcinoma. Br. J. Ophthalmol. (0), 1-6.
 DOI: 10.1136/bjophthalmol-2018-313285. 
CULLEN, J. M., R. PAGE, W. MISDROP (2002): An overview 
of cancer pathogenesis, diagnosis, and management. In: 
Tumors in Domestic Animals. (Meuten, D. J. Ed.), Iowa 
State Press, Iowa, pp. 3-44.
DOBSON, J. M., S. SAMUEL, H. MILSTEIN, K. ROGERS, 
J. L. WOOD (2002): Canine neoplasia in the UK: estimates 
of incidence rates from a population of insured dogs. J. 
Small Anim. Pract. 43, 240-246. 
 DOI: 10.1111/j.1748-5827.2002.tb00066.x
GOLDSCHMIDT, M. H., R. W. DUNSTAN, A. A. 
STANNARD, C. VON TSCHARNER, E. J. WALDER, J. 
A. YAGER (1998): Histologic classification of epithelial 
and melanocytic tumors of the skin of domestic animals. 
Armed Forces Institute of Pathology, Washington DC, pp. 
26-37.
GOLDSCHMIDT, M. H., M. J. HENDRICK (2002): Tumors of 
the skin and soft tissues. In: Tumors in Domestic Animals. 
(Meuten, D. J. Ed.), Iowa State Press, Iowa, pp. 45-117.
GROSS, T. L., P. J. IHRKE, E. J. WALDER, V. K. AFFOLTER 
(2005): Epithelial neoplasms and other tumors. In: Skin 
diseases of the dog and cat. Clinical and Histopathologic 
Diagnosis. 2nd ed., Blackwell Science Ltd, Oxford, pp. 661-
707.
GRÜNTZIG, K., R. GRAF, M. HÄSSIG, M. WELLE, D. 
MEIER, G. LOTT, D. ERNI, N. S. SCHENKER, F. 
GUSCETTI, G. BOO, K. AXHAUSEN, S. FABRIKANT, 
G. FOLKERS, A. POSPISCHIL (2015): The Swiss Canine 
Cancer Registry: a retrospective study on the occurrence 
of tumours in dogs in Switzerland from 1955 to 2008. J. 
Comp. Pathol. 152, 161-171.
 DOI: 10.1016/j.jcpa.2015.02.005
GUDAN KURILJ A., M. HOHŠTETER, B. ARTUKOVIĆ, 
K. SEVERIN, I. C. ŠOŠTARIĆ-ZUCKERMANN, 
A. BECK, S. SEIWERTH, R. SABOČANEC, Ž. 
GRABAREVIĆ (2011): Histopathological evaluation and 
immunohistochemical study of estrogen receptor α, HER-
2 and Ki-67 in canine neoplastic mammary lesions. Vet. 
arhiv 81, 709-722.
HAN, J. I., Y. KIM, D. Y. KIM, K. J. NA (2013): Alteration 
in E-cadherin/β-catenin expression in canine melanotic 
tumors. Vet. Pathol. 50, 274-280.
 DOI: 10.1177/0300985812457792
HARGIS, A. M., P. E. GINN (2008): Skin. In: Special veterinary 
pathology (translated from Croatian) (Grabarević, Ž. Ed.), 
Stanek, Varaždin, Croatia, pp. 807-961.
KARABOLOVSKI, N., A. GUDAN KURILJ, K. SEVERIN, 
M. HOHŠTETER, I.-C. ŠOŠTARIĆ-ZUCKERMANN, L. 
MEDVEN, B. ARTUKOVIĆ, Ž. GRABAREVIĆ (2015): 
An immunohistochemical study of epithelial-mesenchymal 
transition in feline mammary tumors. Book of abstract, 
ESVP-ECVP Annual Meeting, 2-5 September, Helsinki, 
Finland, p. 138.
MORRIS, J., J. DOBSON (2001): Small Animal Oncology. 
Blackwell Science Company, Ames, Iowa, USA. 
POLTON, G. A., M. J. BREARLEY, L. M. GREEN, T. J. 
SCASE (2007): Expression of E-cadherin in canine anal 
sac gland carcinoma and its association with survival. Vet. 
Comp. Oncol. 5, 232-238.
 DOI: 10.1111/j.1476-5829.2007.00131.x
RESTUCCI, B., M. MARTANO, G. DE VICO, L. LO MUZIO, 
P. MAIOLINO (2009): Ekspression of E-Cadherin, 
ß-Catenin and APC protein in Canine Colorectal Tumors. 
Anticancer Res. 29, 2919-2926.
SABATTINI, S., P. BASSI, G. BETTINI (2015): 
Histopathological findings and proliferative activity of 
canine sebaceous gland tumors with a predominant reserve 
cell population. J. Comp. Pathol. 152, 145-152.
 DOI: 10.1016/j.jcpa.2014.12.011
SHAMIR, E. R., A. J. EWALD (2015): Adhesion in mammary 
development: Novel roles for E-Cadherin in individual and 
collective cell migration. Curr. Top. Dev. Biol. 112, 353-
382.
 DOI: 10.1016/bs.ctdb.2014.12.001
SIMKO, E., B. P. WILCOCK, J. A. YAGER (2003): A 
retrospective study of 44 canine apocrine sweat gland 
adenocarcinomas. Can. Vet. J. 44, 38-42. 
ŠOŠTARIĆ-ZUCKERMANN, I.-C.; K. SEVERIN; M. 
HUZAK; M. HOHŠTETER; A. GUDAN KURILJ; B. 
ARTUKOVIĆ; A. DŽAJA; Ž. GRABAREVIĆ (2016): 
Quantification of morphology of canine circumanal gland 
tumors: a fractal based study. Eur. J. Histochem. 60, 91-98.
 DOI: 10.4081/ejh.2016.2609
ŠOŠTARIĆ-ZUCKERMANN, I.-C., K. SEVERIN, M. 
HOHŠTETER, B. ARTUKOVIĆ, A. BECK, A. GUDAN 
KURILJ, R. SABOČANEC, P. DŽAJA, Ž. GRABAREVIĆ 
(2013): Incidence and types of canine tumours in Croatia. 
Vet. arhiv 83, 31-45.
WIJNHOVEN, B. P. L., W. N. M. DINJENS, M. PIGNATELLI 
(2000): E-cadherin-catenin cell-cell adhesion complex and 
human cancer. Br. J. Surg. 87, 992-1005.
 DOI: 10.1046/j.1365-2168.2000.01513.x
M. Hohšteter et al.: Expression of E-cadherin and Ki-67 in canine apocrine and sebaceous gland tumors
Vet. arhiv 91 (1), 51-63, 2021 63
Received: 29 July 2019
Accepted: 19 October 2020
_____________________________________________________________________________
HoHŠteter, M., I.-C. ŠoŠtArIć-ZuCKerMAnn, I. MIHoKovIć BuHIn, L. Medven 
ZAGrAdIŠnIK, B. ArtuKovIć, A. BeCK, A. GudAn KurILj: ekspresija e-kadherina i Ki-67 u 
tumorima apokrinih i lojnih žlijezda kože pasa. vet. arhiv 91, 51-63, 2021.
SAŽETAK
U radu je istraživana učestalost pojedinih histoloških tipova 13 tumora apokrinih i 22 tumora lojnih žlijezda u pasa 
čiji su uzorci dostavljeni na histopatološku dijagnostiku na Zavod za veterinarsku patologiju Veterinarskog fakulteta 
u Zagrebu, u razdoblju od 1. siječnja 2010. do 31. prosinca 2012. godine. Utvrđivano je postoji li povezanost između 
imunohistokemijske ekspresije E-kadherina i tipa tumora te postoji li povezanost ekspresije E-kadherina i Ki-67 
vezano uz biološko ponašanje tumora. Prosječna dob oboljelih životinja iznosila je 10,15 godina za tumore apokrinih 
žlijezda, a za tumore lojnih žlijezda 10,91 godina. Histopatološkom klasifikacijom tumora ustanovljeno je 53,8 % 
karcinoma i 46,2 % adenoma apokrinih žlijezda, a za tumore lojnih žlijezda 50,0 % epitelioma, 36,4 % adenoma te 
13,6 % karcinoma. Vrijeme preživljavanja pasa s tumorima lojnih žlijezda bilo je najkraće kod epitelioma, srednje 
vrijeme preživljavanjea bilo je kod adenoma, a najdulje kod karcinoma. Metastaziranje je potvrđeno kod malog broja 
adenoma i epitelioma, a učestalost recidiva bila je najveća kod karcinoma lojnih žlijezda. Kod tumora apokrinih 
žlijezda utvrđeno je približno podjednako vrijeme preživljavanja za adenome i karcinome te češće metastaziranje i 
recidiviranje karcinoma u odnosu na adenome. Imunohistokemijskom analizom dokazano je da analiza ekspresije 
E-kadherina i Ki-67 može koristiti u određivanju točnije dijagnoze tipa tumora apokrinih, a osobito tumora lojnih 
žlijezda pasa. Također, utvrđeno je da kod tumora lojnih žlijezda lokalizacija i intenzitet ekspresije E-kadherina 
mogu pomoći pri određivanju prognoze, odnosno biološkom ponašanju tumora. Ekspresija E-kadherina u tumorima 
apokrinih žlijezda pasa u provedenom istraživanju nije pokazala rezultate koji bi upućivali na povezanost rezultata 
imunohistokemijske pretrage i biološkog ponašanja tumora.
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